Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Personalized treatment for relapsed/refractory acute leukemia
NCT02551718Completed
- Sponsor
- University of Washington
- Start
- Sep 2015
- Primary completion
- Jun 2020
- Countries
- 1
01
Overview
Open-label trial in acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) and acute leukemia of ambiguous lineage (ALAL), sponsored by University of Washington. Started Sep 2015; status: completed.
02
Conditions
acute myeloid leukemia (AML)acute lymphoblastic leukemia (ALL)acute leukemia of ambiguous lineage (ALAL)
Beyond the preview
Go deeper on NCT02551718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02551718.